Embody Revenue and Competitors

Embody, LLC is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address unmet needs in soft tissue restoration and regeneration. Embody's core technology and expertise is in nanoscale material design and fabrication. Embody's implantable materials have the potential to direct and modulate the body's own healing response, resulting in faster recovery, better outcomes and improved functionality, and return to pre-injury performance for the patient. Embody is currently focusing on product applications for the Achilles tendon, Rotator Cuff repair, with the longer term goal to develop an engineered anterior cruciate ligament (ACL) replacement. Current treatment options for these indications are unrefined, resulting in significant patient disability due to extended recovery times, and failure to recover pre-injury performance, strength, and function. Regenerative matrices designed through Embody's nano-to-product scale technologies will address these limitations and improve outcomes for over 2M patients annually affected by soft tissue injuries in the Unites States alone. We have a uniquely qualified team of scientists and engineers whose combination of biofabrication and collagen science expertise is enabling us to invent advanced manufacturing methods, novel biomaterials and advance cellular remodeling.